Louis Champel
Director/Board Member en VETOQUINOL SA .
Perfil
Louis Champel is an Independent Director at Vétoquinol SA since 2009.
Prior to this, he was the Chief Executive Officer at Rhone Merieux.
He also served as the Chairman & Chief Executive Officer at Merial SAS from 1997 to 2000.
From 2002 to 2008, he was the Managing Director at Lyon 3 Valorisation.
Mr. Champel completed his undergraduate degree at Sciences Po.
Cargos activos de Louis Champel
Empresas | Cargo | Inicio |
---|---|---|
VETOQUINOL SA | Director/Board Member | 22/09/2010 |
Antiguos cargos conocidos de Louis Champel.
Empresas | Cargo | Fin |
---|---|---|
Lyon 3 Valorisation | Chief Executive Officer | 01/01/2008 |
Merial SAS
Merial SAS Pharmaceuticals: MajorHealth Technology Merial SAS develops, manufactures, and distributes pharmaceutical products and vaccines for animals. It provides therapeutic medicines that treat the diseases of dogs, cats, chickens, cows, pigs, and horses. The company was founded in 1997 and is headquartered in Treillieres, France. | Chief Executive Officer | 01/01/2000 |
Rhone Merieux
Rhone Merieux Chemicals: SpecialtyProcess Industries Part of Zoetis, Inc., Rhone Merieux manufactures pharmaceuticals, specialty, and agricultural chemicals. | Chief Executive Officer | - |
Formación de Louis Champel.
Sciences Po | Undergraduate Degree |
Experiencias
Funciones ocupadas
Activas
Inactivas
Empresas cotizadas
Empresas privadas
Relaciones
Relaciones de 1er grado
Empresas vinculadas al 1er grado
Hombre
Mujer
Administradores
Ejecutivos
Empresas relacionadas
Empresas cotizadas | 1 |
---|---|
VETOQUINOL SA | Health Technology |
Empresas privadas | 3 |
---|---|
Rhone Merieux
Rhone Merieux Chemicals: SpecialtyProcess Industries Part of Zoetis, Inc., Rhone Merieux manufactures pharmaceuticals, specialty, and agricultural chemicals. | Process Industries |
Merial SAS
Merial SAS Pharmaceuticals: MajorHealth Technology Merial SAS develops, manufactures, and distributes pharmaceutical products and vaccines for animals. It provides therapeutic medicines that treat the diseases of dogs, cats, chickens, cows, pigs, and horses. The company was founded in 1997 and is headquartered in Treillieres, France. | Health Technology |
Lyon 3 Valorisation |
- Bolsa de valores
- Insiders
- Louis Champel